Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.

What It Covers

The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and CJC-1295 (no DAC), Mod GRF 1-29, published as a review.

The study used "netnography" to explore female use of CJC-1295, a synthetic growth hormone analogue from the perspectives contained in Internet forum activity.

Who the Included Studies Covered

PubMed tags the participants as women only.

A systematic Internet search was conducted using variation of the term "CJC-1295"; and combined with "forum." Ninety-six hits related to bodybuilding websites where CJC-1295 was mentioned.

Following application of exclusion criteria to confine to female use and evidence of forum activity, 9 sites remained.

How the Review Was Done

These were searched internally for reference to CJC-1295.

Twenty-three discussion threads relating to female use of CJC-1295 formed the end data set, and analyzed using the Empirical Phenomenological Psychological method.

What Was Measured

Topics PubMed links to this paper include Body Image, Decision Making, Growth Hormone-Releasing Hormone, Human Growth Hormone, Peptide Fragments and Self Care.

Author keywords: CJC-1295 and netnography.

What This Means in Plain Language

This is a review of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and CJC-1295 (no DAC), Mod GRF 1-29.

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2016 (Substance use & misuse), a journal based in England.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page and the CJC-1295 (no DAC), Mod GRF 1-29 compound page, all human trials.